Literature DB >> 7964748

Tau phosphorylation in human, primate, and rat brain: evidence that a pool of tau is highly phosphorylated in vivo and is rapidly dephosphorylated in vitro.

T D Garver1, K A Harris, R A Lehman, V M Lee, J Q Trojanowski, M L Billingsley.   

Abstract

The extent of tau phosphorylation is thought to regulate the binding of tau to microtubules: Highly phosphorylated tau does not bind to tubules, whereas dephosphorylated tau can bind to microtubules. It is interesting that the extent of tau phosphorylation in vivo has not been accurately determined. Tau was rapidly isolated from human temporal neocortex and hippocampus, rhesus monkey temporal neocortex, and rat temporal neocortex and hippocampus under conditions that minimized dephosphorylation. In brain slices, we observed that tau isolated under such conditions largely existed in several phosphorylated states, including a pool that was highly phosphorylated; this was determined using epitope-specific monoclonal and polyclonal antibodies. This highly phosphorylated tau was dephosphorylated during a 120-min time course in vitro, presumably as a result of neuronal phosphatase activity. The slow-mobility forms of tau were shifted to faster-mobility forms following in vitro incubation with alkaline phosphatase. Laser densitometry was used to estimate the percent of tau in slow-mobility, highly phosphorylated forms. Approximately 25% of immunoreactive tau was present as slow-mobility (66- and 68-kDa) forms of tau. The percentage of immunoreactive tau in faster-mobility pools (42-54 kDa) increased in proportion to the decrease in content of 66-68-kDa tau as a function of neuronal phosphatases or alkaline phosphatase treatment. These data suggest that the turnover of phosphorylated sites on tau is rapid and depends on neuronal phosphatases. Furthermore, tau is highly phosphorylated in normal-appearing human, primate, and rodent brain.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7964748     DOI: 10.1046/j.1471-4159.1994.63062279.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  11 in total

Review 1.  Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration.

Authors:  M L Billingsley; R L Kincaid
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

2.  Early Alzheimer's disease-type pathology in the frontal cortex of wild mountain gorillas (Gorilla beringei beringei).

Authors:  Sylvia E Perez; Chet C Sherwood; Michael R Cranfield; Joseph M Erwin; Antoine Mudakikwa; Patrick R Hof; Elliott J Mufson
Journal:  Neurobiol Aging       Date:  2015-12-31       Impact factor: 4.673

3.  Phosphorylation of tau by glycogen synthase kinase 3beta affects the ability of tau to promote microtubule self-assembly.

Authors:  M A Utton; A Vandecandelaere; U Wagner; C H Reynolds; G M Gibb; C C Miller; P M Bayley; B H Anderton
Journal:  Biochem J       Date:  1997-05-01       Impact factor: 3.857

4.  Stress-induced tau phosphorylation in mouse strains with different brain Erk 1 + 2 immunoreactivity.

Authors:  A Y Korneyev
Journal:  Neurochem Res       Date:  1998-12       Impact factor: 3.996

Review 5.  Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease.

Authors:  C-X Gong; K Iqbal
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

6.  Staging of Alzheimer's pathology in triple transgenic mice: a light and electron microscopic analysis.

Authors:  Kwang-Jin Oh; Sylvia E Perez; Sarita Lagalwar; Laurel Vana; Lester Binder; Elliott J Mufson
Journal:  Int J Alzheimers Dis       Date:  2010-07-15

7.  Neurofibrillary degeneration in amyotrophic lateral sclerosis/parkinsonism-dementia complex of Guam. Immunochemical characterization of tau proteins.

Authors:  V Buée-Scherrer; L Buée; P R Hof; B Leveugle; C Gilles; A J Loerzel; D P Perl; A Delacourte
Journal:  Am J Pathol       Date:  1995-04       Impact factor: 4.307

8.  Tau phosphorylation sites work in concert to promote neurotoxicity in vivo.

Authors:  Michelle L Steinhilb; Dora Dias-Santagata; Tudor A Fulga; Daniel L Felch; Mel B Feany
Journal:  Mol Biol Cell       Date:  2007-10-10       Impact factor: 4.138

9.  In situ visualization of intratumor growth factor signaling: immunohistochemical localization of activated ERK/MAP kinase in glial neoplasms.

Authors:  J W Mandell; I M Hussaini; M Zecevic; M J Weber; S R VandenBerg
Journal:  Am J Pathol       Date:  1998-11       Impact factor: 4.307

10.  Tyrosine phosphorylation of tau by the SRC family kinases lck and fyn.

Authors:  Timothy Me Scales; Pascal Derkinderen; Kit-Yi Leung; Helen L Byers; Malcolm A Ward; Caroline Price; Ian N Bird; Timothy Perera; Stuart Kellie; Ritchie Williamson; Brian H Anderton; C Hugh Reynolds
Journal:  Mol Neurodegener       Date:  2011-01-26       Impact factor: 14.195

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.